Kumiko Hirayama
Overview
Explore the profile of Kumiko Hirayama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tomita M, Yamamoto M, Hirayama K, Kyo A, Misawa N, Kinari G, et al.
J Clin Med
. 2024 Aug;
13(16).
PMID: 39200783
To evaluate the one-year outcomes of intravitreal ranibizumab biosimilar (RBZ-BS) injections for myopic choroidal neovascularization (mCNV) in Japanese patients. Twenty-one patients (mean age 69.0 years; 4 males, 17 females) with...
2.
Hirayama K, Yamamoto M, Honda S, Kyo A, Misawa N, Kohno T
J Clin Med
. 2024 Aug;
13(15).
PMID: 39124642
To purpose of this study was to retrospectively evaluate the 1-year outcomes and factors associated with the treatment responsiveness of switching to intravitreal brolucizumab (IVBR) for neovascular age-related macular degeneration...
3.
Nihei A, Yamamoto M, Hirayama K, Kyo A, Misawa N, Kohno T, et al.
Am J Ophthalmol Case Rep
. 2024 Jun;
35:102078.
PMID: 38846070
Purpose: Anti-vascular endothelial growth factor (VEGF) therapy is the most prevalent intervention for exudative lesions secondary to neovascular age-related macular degeneration (nAMD) and other macular neovascularization (MNV). However, in some...
4.
Yamamoto M, Miura Y, Hirayama K, Kyo A, Kohno T, Theisen-Kunde D, et al.
Life (Basel)
. 2023 Mar;
13(3).
PMID: 36983925
The purpose of this study was to compare the safety and efficacy of selective retina therapy (SRT) combined with the intravitreal injection of ranibizumab (IVR) in patients with macular edema...
5.
Yamada-Okahara N, Kyo A, Hirayama K, Yamamoto M, Kohno T, Honda S
Jpn J Ophthalmol
. 2023 Mar;
67(3):295-300.
PMID: 36867256
Purpose: Persistent central serous chorioretinopathy (pCSC) may be treated by laser photocoagulation (PC), selective retina therapy (SRT), or photodynamic therapy (PDT). We conducted retrospective analyses regarding the choice of therapy...
6.
Honda S, Kohno T, Yamamoto M, Hirayama K, Kyo A, Hirabayashi M, et al.
Sci Rep
. 2022 Jun;
12(1):9105.
PMID: 35650246
The purpose of this study was to investigate the occurrence rate and predictors of photodynamic therapy (PDT) induced acute exudative maculopathy (PAEM). This retrospective study included 39 eyes of 39...
7.
Kyo A, Yamamoto M, Hirayama K, Kohno T, Theisen-Kunde D, Brinkmann R, et al.
Sci Rep
. 2021 Apr;
11(1):8973.
PMID: 33903643
The purpose of this study was to investigate the factors of clinical outcome of selective retina therapy (SRT) for central serous chorioretinopathy (CSC). This retrospective study included 77 eyes of...
8.
Tamachi T, Kohno T, Yamamoto M, Hirayama K, Kyo A, Ueda N, et al.
Ophthalmol Ther
. 2020 Oct;
9(4):1069-1082.
PMID: 33058069
Introduction: To evaluate 1-year outcomes of intravitreal aflibercept (IVA) using a treat-and-extend (TAE) regimen for polypoidal choroidal vasculopathy (PCV) and identify the factors for patients whose treatment intervals could be...
9.
Hirayama K, Yamamoto M, Kohno T, Kyo A, Theisen-Kunde D, Brinkmann R, et al.
Graefes Arch Clin Exp Ophthalmol
. 2020 Sep;
259(2):387-393.
PMID: 32960320
Purpose: Tilted disc syndrome (TDS) may be associated with a macular serous retinal detachment (MSRD). However, ideal therapy for this complication is still unestablished yet to date. The purpose of...
10.
Yamamoto M, Miura Y, Kyo A, Hirayama K, Kohno T, Theisen-Kunde D, et al.
Am J Ophthalmol Case Rep
. 2020 Jul;
19:100794.
PMID: 32637732
Purpose: To report a case of a patient with subretinal fluid (SRF) associated with choroidal nevus (CN), who was treated with selective retina therapy (SRT) and ultimately achieved resolution of...